Fund shareholders of Summit Therapeutics Inc
ISIN US86627T1088 · United States
- Fund shareholders
- 167
- Of which ETFs
- 46 121 other funds
- Value held
- 727.4M $ 1.1M € · 8.1M SEK
- Share of capital
- 4.9 % of 797.7M shares on Jul 17, 2026
167 funds hold this company. This table lists the 166 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| iShares Morningstar Growth ETF iShares Trust | 9,952 | 213.6K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Core ETF Columbia ETF Trust I | 9,805 | 210.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Index Fund T. ROWE PRICE INDEX TRUST, INC. | 9,636 | 182.7K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Large Cap Growth Index Fund Fidelity Salem Street Trust | 9,495 | 203.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 9,415 | 156.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Venerable Mid Cap Index Fund Venerable Variable Insurance Trust | 9,346 | 177.2K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 8,075 | 173.3K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD GROWTH AND INCOME FUND VANGUARD QUANTITATIVE FUNDS | 7,900 | 149.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Growth Equity Index Fund GuideStone Funds | 7,862 | 149.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 7,725 | 128.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| EQ/Large Cap Growth Managed Volatility Portfolio EQ Advisors Trust | 7,111 | 134.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Dow Jones U.S. ETF iShares Trust | 6,361 | 136.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 6,132 | 116.3K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya RussellTM Mid Cap Index Portfolio Voya VARIABLE PORTFOLIOS INC | 5,832 | 110.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| FlexShares Morningstar US Market Factor Tilt Index Fund FlexShares Trust | 5,027 | 107.9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 5,000 | 83K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,955 | 82.2K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MarketBeta U.S. 1000 Equity ETF Goldman Sachs ETF Trust II | 4,910 | 81.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 4,901 | 92.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Large-Cap Growth Index Portfolio PACIFIC SELECT FUND | 4,272 | 81K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Large Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,253 | 70.6K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| LargeCap Growth Fund I Principal Funds, Inc | 4,234 | 90.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 4,091 | 77.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 3,923 | 74.4K $ | 0.70 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT LARGE CAP INDEX FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 3,900 | 64.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 3,826 | 72.5K $ | 0.48 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 3,554 | 67.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 3,507 | 75.3K $ | 0.75 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VOYA RUSSELLTM MID CAP GROWTH INDEX PORTFOLIO Voya VARIABLE PORTFOLIOS INC | 2,898 | 54.9K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Voya VACS Index Series MC Portfolio Voya VARIABLE PORTFOLIOS INC | 2,717 | 51.5K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PD Mid-Cap Index Portfolio PACIFIC SELECT FUND | 2,635 | 50K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 2,552 | 48.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 2,435 | 46.2K $ | 0.24 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 2,425 | 52K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SIMT LARGE CAP INDEX FUND SEI INSTITUTIONAL MANAGED TRUST | 2,400 | 45.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL Russell 1000 Growth Index Fund Allianz Variable Insurance Products Trust | 2,391 | 45.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Multimanager Aggressive Equity Portfolio EQ Advisors Trust | 2,300 | 43.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar U.S. Equity ETF iShares Trust | 2,192 | 47K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs MarketBeta(R) Russell 1000 Growth Equity ETF Goldman Sachs ETF Trust | 1,892 | 31.4K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Growth Fund VALIC Co I | 1,729 | 28.7K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 1,701 | 28.2K $ | 0.10 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,658 | 31.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| John Hancock Multifactor Large Cap ETF John Hancock Exchange-Traded Fund Trust | 1,428 | 27.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 1,276 | 24.2K $ | 0.19 % | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 1,273 | 24.1K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 1,170 | 19.4K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Wilmington Large-Cap Strategy Fund Wilmington Funds | 1,150 | 24.7K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| The Institutional U.S. Equity Portfolio HC Capital Trust | 904 | 17.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 822 | 15.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 816 | 17.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 800 | 15.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 785 | 16.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 736 | 12.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco QQQ Hedged Advantage ETF Invesco Actively Managed Exchange-Traded Fund Trust | 692 | 14.9K $ | 0.12 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 573 | 10.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 557 | 12K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| AMT Diversified Equity Fund ADVISER MANAGED TRUST | 555 | 11.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LargeCap Growth Account I Principal Variable Contract Funds, Inc | 535 | 10.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 514 | 9.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 484 | 10.4K $ | 0.07 % | 0.00 % | as of Apr 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 408 | 8.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 180 | 3.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 24 | 455 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1 | 19 $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 640K € | 0.77 % | as of Dec 31, 2025 ↗ | ||
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 506.7K € | 1.36 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.36 % | as of Dec 31, 2025 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.24 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 1.21 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 1.15 % | as of Apr 30, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 1.15 % | as of Feb 28, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 1.09 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 1.08 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 1.04 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1.04 % | as of Mar 31, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 1.01 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 163 | -10 | 39,424,224 | -5.2 % |
| 2026Q1 | 173 | 0 | 41,579,277 | +21.2 % |
| 2025Q4 | 173 | -19 | 34,307,598 | +12.5 % |
| 2025Q3 | 192 | -26 | 30,502,278 | -9.7 % |
| 2025Q2 | 218 | +37 | 33,781,435 | +7.1 % |
| 2025Q1 | 181 | +15 | 31,541,381 | +10.8 % |
| 2024Q4 | 166 | +38 | 28,462,542 | -6.2 % |
| 2024Q3 | 128 | +8 | 30,351,670 | -8.2 % |
| 2024Q2 | 120 | +24 | 33,056,019 | +78.1 % |
| 2024Q1 | 96 | +7 | 18,555,239 | +15.8 % |
| 2023Q4 | 89 | 16,029,010 |
Institutional managers
216 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 36,391,063 | 690M $ | as of Mar 31, 2026 |
| FMR LLC | 10,853,199 | 205.8M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 9,653,758 | 183M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 8,277,859 | 156.9K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,028,160 | 133.3M $ | as of Mar 31, 2026 |
| UBS Group AG | 3,680,315 | 69.8M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,315,854 | 62.9M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,242,229 | 42.5M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,650,591 | 31.3M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,323,179 | 24M $ | as of Mar 31, 2026 |
| APEIRON CAPITAL Ltd | 1,309,141 | 24.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 981,185 | 18.6M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 960,867 | 18.2M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 956,894 | 18.1M $ | as of Mar 31, 2026 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 892,873 | 16.9M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 784,186 | 14.9M $ | as of Mar 31, 2026 |
| Rock Springs Capital Management LP | 710,000 | 13.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 665,364 | 12.6M $ | as of Mar 31, 2026 |
| Squarepoint Ops LLC | 613,877 | 11.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 603,933 | 11.5M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 598,692 | 11.4M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 592,810 | 11.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 581,600 | 11M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 548,335 | 10.4M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 540,662 | 10.3M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Summit Therapeutics Inc". https://titelia.com/en/stocks/summit-therapeutics-inc-US86627T1088